Lozapin 25mg Tablet contains Clozapine, an atypical antipsychotic primarily indicated for the treatment of schizophrenia, particularly in patients who are resistant to other antipsychotic therapies. Clozapine exerts its therapeutic effects by modulating neurotransmitter activity in the brain, notably through antagonism of dopamine D2 and serotonin 5-HT2A receptors, which helps alleviate both positive and negative symptoms of schizophrenia. Lozapin is also utilized in reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. The 25mg dosage allows for careful titration to minimize adverse effects, which may include agranulocytosis, seizures, myocarditis, sedation, hypersalivation, and orthostatic hypotension. Due to the risk of severe neutropenia, regular monitoring of white blood cell counts is mandatory during treatment. Initiation and dose adjustments should be conducted under strict medical supervision with appropriate hematological monitoring. Clozapine is contraindicated in patients with a history of clozapine-induced agranulocytosis or severe granulocytopenia. Lozapin should be used cautiously in individuals with cardiovascular disease, epilepsy, or hepatic impairment. Adherence to prescribed dosing and monitoring protocols is essential to ensure safety and optimize therapeutic outcomes.